A BITTER PILL

When Aleve, the much-heralded nonprescription version of naproxen sodium, made the over-the-counter switch in June 1994, it was the biggest thing to hit the analgesics market since ibuprofen made the switch a decade earlier.Some analysts had projected that the OTC product, manufactured by Syntex Corp. and marketed by Procter & Gamble Co., would add $200 million to the $2.5 billion-plus analgesics

When Aleve, the much-heralded nonprescription version of naproxen sodium, made the over-the-counter switch in June 1994, it was the biggest thing to hit the analgesics market since ibuprofen made the switch a decade earlier.

Some analysts had projected that the OTC product, manufactured by Syntex Corp. and marketed by Procter & Gamble Co., would add $200 million to the $2.5 billion-plus analgesics market.

Fifteen months later, supermarket retailers are scratching their hea

Register to view the full article

test - Advanced Registered User

Already a member? .